MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Climate Change Indices and The Vulnerability of Parkinson’s Patients in The MENA Region And North Africa: A Narrative Review

    MYA. Amine, F. Essam (Giza, Egypt)

    Objective: Through a (SWOT) analysis, this study looked at the climate change indices and the susceptibility of Parkinson's patients in the MENA region and North…
  • 2024 International Congress

    Neuropeptide Alterations in Parkinson’s Disease: A Meta-Analysis

    MA. Muneer, V. Suresh, S. Aujla, A. Khare, P. Gowda, V. Ghosh, T. Dave (Lahore, Pakistan)

    Objective: To analyze the levels of different neuropeptides in patients with Parkinson’s disease (PD) compared to healthy individuals. Background: Neuropeptides are bioactive molecules that play…
  • 2024 International Congress

    Burden of Movements Disorders at Initiative Plus Center Hospital

    P. Kiatoko, K. Luse (KINSHASA, The Democratic Republic of the Congo)

    Objective: describe the socio-demographic, clinical characteristics and evolutionary profiles of patients followed for movement disorders Background: The DR Congo specialists in abnormal movements are rare,…
  • 2024 International Congress

    Misdiagnosing Movement Disorders on a Terciary Academic Center in the Caribbean: A Series of Cases

    S. Castro, C. Torres, W. Castro, J. Carbonell, I. Zabala, A. de Peña, V. Espaillat, D. Santos, P. Roa, F. Taveras, Y. Suero (Distrito Nacional, Dominican Republic)

    Objective: To report 10 movement disorder cases misdiagnosed by general neurologists as another disorder or a different category of movement disorder. Background: The misdiagnosis of…
  • 2024 International Congress

    EMPOWER-PD: Testing and evaluation of an 8-week co-created Self-management program tailored People with Parkinson`s disease and their caregivers in an interventional follow-up study

    T. Thomsen, S. Skovbølling, M. Brønden, M. Møller, J. Frederiksen, B. Biering-Sørensen (Roskilde, Denmark)

    Objective: This study aims to test a 8-week self-management program, developed collaboratively with People with PD (PwP), caregivers, healthcare professionals and other stakeholders using a…
  • 2024 International Congress

    Scoping Review of Caregiver Burden in Parkinson’s Disease

    S. Luehrsen, I. Pretzer-Aboff, R. Brown (Richmond, USA)

    Objective: To evaluate caregiver burden and stress in Parkinson’s disease and factors that may influence different burden and stress levels. Background: N/A Method: A systematic…
  • 2024 International Congress

    Co-morbid Hypertension and Diabetes and the Relationship to Parkinson’s Disease Motor Phenotype in the Nigeria Parkinson’s Disease Research Network Registry

    E. Iwuozo, O. Ojo, O. Agabi, N. Okubadejo, NPD. Research Network (Makurdi, Nigeria)

    Objective: To determine the frequency of hypertension (HBP) and type 2 diabetes mellitus (T2DM) as comorbidities in the Nigerian PD Research network (NPDR) cohort, and…
  • 2024 International Congress

    Demographics of Botulinum toxin therapy population representative to demographics in Essex County, USA

    B. Puccio, Y. Xu, J. Acquaviva, E. Feinstein (Newark, USA)

    Objective: To describe and compare the demographics of patients receiving botulinum toxin therapy in a single movement disorder clinic to the broader surrounding community. Background:…
  • 2024 International Congress

    Plasma MicroRNA Expression Profiling in patients with Multiple System Atrophy and Parkinson’s Disease

    R. Yadav, P. Ramaswamy, PK. Pal, R. Christopher (Bengaluru, India)

    Objective: Our objective was to identify differentially expressed, circulating miRNAs in Multiple System Atrophy-Parkinsonian type (MSA-P) and Parkinson’s disease (PD) which could serve as diagnostic…
  • 2024 International Congress

    Pain types in multiple system atrophy: results from a community-based survey

    N. Campese, G. Göbel, L. Kaltenbach, J. Wanschitz, A. Schlager, B. Caliò, F. Leys, P. Bower, L. Kellermann, L. Zamarian, K. Bannister, R. Chauhuri, A. Schrag, R. Freeman, H. Kaufmann, R. Granata, S. Kiechl, W. Poewe, K. Seppi, G. Wenning, A. Fanciulli (Innsbruck, Austria)

    Objective: To assess the frequency of different pain types in multiple system atrophy (MSA). Background: According to a recent meta-analysis, up to 60% of individuals…
  • « Previous Page
  • 1
  • …
  • 55
  • 56
  • 57
  • 58
  • 59
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley